Alliance Pharma plc (LON:APH)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $69.60. Alliance Pharma shares last traded at $68.80, with a volume of 253,054 shares trading hands.
Separately, Numis Securities restated a “buy” rating and set a GBX 1,800 ($23.52) price target on shares of in a research note on Monday, June 3rd.
The company has a quick ratio of 0.39, a current ratio of 0.64 and a debt-to-equity ratio of 39.31. The company has a market capitalization of $357.17 million and a PE ratio of 19.11. The company’s 50-day moving average price is GBX 73.59.
Alliance Pharma plc operates as a specialty pharmaceutical company in the United Kingdom, rest of Europe, and internationally. The company acquires, markets, and sells pharmaceutical products. It acquires the rights of established products, and owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products.
Featured Story: Institutional Investors
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.